Psykey, Inc.

CEOSOTCHealthcare● Active

$0.00

$-0.00(-39.19%)

Market Cap$64600

P/E Ratio—

52W High$0.0125

52W Low$0.0006

Avg Volume142K

Open$0.01

Beta0.27

Free Cash Flow Financials Revenue

Psykey, Inc. (CEOS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CEOS · free cash flow · updated Jun 9, 2026

Core FCF metrics

CEOS · FCF · TTM · margin & CAGR

Free cash flow was $0 for FY2025 (fiscal year ending 2025-12-31), down 100.0% year-over-year

FY2025 Free Cash Flow$0▼ -100.0% YoY

Trailing 12M (TTM)$841,568trailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CEOS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.0M(1M)$0▼ 100.0%—

FY2024$2.1M(0M)$2.0M—32.6%

FY2023$159,759(0M)$0▲ +100.0%0.0%

FY2022−$92,891(0M)−$92,891▼ 0.6%-480.9%

FY2021−$92,312(0M)−$92,312▼ 58897.5%—

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CEOS · P/FCF · FCF yield · FCF per share

Psykey, Inc. (CEOS) trades at a FCF yield of 0.00% and a price-to-free-cash-flow ratio of N/A. FCF per share stands at $0.00, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

0.00%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.00

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

x0.0

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CEOS · cash flow statement · operating / investing / financing

For FY2025, Psykey, Inc. generated $1.0M in operating cash flow and spent 1M in capital expenditures, yielding $0 in free cash flow.

Operating Activities

+$1.0M

Cash from core business operations

2025-12-31

Investing Activities

−$0.3M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$0.2M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($1.0M) − |CapEx| (1M) = FCF ($0)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CEOS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Psykey, Inc.YOU

CEOS

$0-100.0%—

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Psykey, Inc. (CEOS) reported free cash flow of $0 for FY2025 (fiscal year ending 2025-12-31), down 100.0% year-over-year.

Based on available data, Psykey, Inc. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $2.0M in FY2024.

Psykey, Inc.'s FCF yield is 0.00% and price-to-FCF ratio is N/A for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CEOS free cash flow · 8 questions

Psykey, Inc. free cash flow was $0 for FY2025, down 100.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $841,568.

CEOS free cash flowCEOS FCFCEOS FCF 2025CEOS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Psykey, Inc. · Psykey, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026